Search research articles
Contact Us
Filters
Showing results (481-490 of 565) with videos related to
Page
of 57
Sort By:
American Heart Journal
|
September 18, 2012
Edifoligide and long-term outcomes after coronary artery bypass grafting: PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT IV) 5-year results
Renato D Lopes, Judson B Williams, Rajendra H Mehta, et al.
Circulation
|
December 6, 2012
Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts
Jonathan P Piccini, Susanna R Stevens, YuChiao Chang, et al.
European Heart Journal
|
October 18, 2013
Ischaemic cardiac outcomes in patients with atrial fibrillation treated with vitamin K antagonism or factor Xa inhibition: results from the ROCKET AF trial
Kenneth W Mahaffey, Susanna R Stevens, Harvey D White, et al.
American Heart Journal
|
August 25, 2015
Predictors of clinical outcomes in acute decompensated heart failure: Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure outcome models
Prateeti Khazanie, Gretchen M Heizer, Vic Hasselblad, et al.
American Heart Journal
|
August 25, 2015
Diuretic response in acute heart failure-an analysis from ASCEND-HF
Jozine M ter Maaten, Allison M Dunning, Mattia A E Valente, et al.
American Heart Journal
|
November 2, 2013
Incidence of atrial fibrillation in a population with impaired glucose tolerance: the contribution of glucose metabolism and other risk factors. A post hoc analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial
Roberto Latini, Lidia Staszewsky, Jie-Lena Sun, et al.
Circulation
|
July 28, 2010
Pathogenesis of sudden unexpected death in a clinical trial of patients with myocardial infarction and left ventricular dysfunction, heart failure, or both
Anne-Catherine Pouleur, Ebrahim Barkoudah, Hajime Uno, et al.
Circulation
|
November 21, 2007
Time to coronary angiography and outcomes among patients with high-risk non ST-segment elevation acute coronary syndromes: results from the SYNERGY trial
Pierluigi Tricoci, Yuliya Lokhnygina, Lisa G Berdan, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 6, 2005
A nitric oxide processing defect of red blood cells created by hypoxia: deficiency of S-nitrosohemoglobin in pulmonary hypertension
Timothy J McMahon, Gregory S Ahearn, Martin P Moya, et al.
American Heart Journal
|
July 29, 2014
Independent data monitoring committees: preparing a path for the future
Connie N Hess, Matthew T Roe, C Michael Gibson, et al.
Page
of 57
Search research articles
Search
Showing results (481-490 of 565) with videos related to
Sort By:
Page
of 57
American Heart Journal
|
September 18, 2012
Edifoligide and long-term outcomes after coronary artery bypass grafting: PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT IV) 5-year results
Renato D Lopes, Judson B Williams, Rajendra H Mehta, et al.
Circulation
|
December 6, 2012
Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts
Jonathan P Piccini, Susanna R Stevens, YuChiao Chang, et al.
European Heart Journal
|
October 18, 2013
Ischaemic cardiac outcomes in patients with atrial fibrillation treated with vitamin K antagonism or factor Xa inhibition: results from the ROCKET AF trial
Kenneth W Mahaffey, Susanna R Stevens, Harvey D White, et al.
American Heart Journal
|
August 25, 2015
Predictors of clinical outcomes in acute decompensated heart failure: Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure outcome models
Prateeti Khazanie, Gretchen M Heizer, Vic Hasselblad, et al.
American Heart Journal
|
August 25, 2015
Diuretic response in acute heart failure-an analysis from ASCEND-HF
Jozine M ter Maaten, Allison M Dunning, Mattia A E Valente, et al.
American Heart Journal
|
November 2, 2013
Incidence of atrial fibrillation in a population with impaired glucose tolerance: the contribution of glucose metabolism and other risk factors. A post hoc analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial
Roberto Latini, Lidia Staszewsky, Jie-Lena Sun, et al.
Circulation
|
July 28, 2010
Pathogenesis of sudden unexpected death in a clinical trial of patients with myocardial infarction and left ventricular dysfunction, heart failure, or both
Anne-Catherine Pouleur, Ebrahim Barkoudah, Hajime Uno, et al.
Circulation
|
November 21, 2007
Time to coronary angiography and outcomes among patients with high-risk non ST-segment elevation acute coronary syndromes: results from the SYNERGY trial
Pierluigi Tricoci, Yuliya Lokhnygina, Lisa G Berdan, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 6, 2005
A nitric oxide processing defect of red blood cells created by hypoxia: deficiency of S-nitrosohemoglobin in pulmonary hypertension
Timothy J McMahon, Gregory S Ahearn, Martin P Moya, et al.
American Heart Journal
|
July 29, 2014
Independent data monitoring committees: preparing a path for the future
Connie N Hess, Matthew T Roe, C Michael Gibson, et al.
Page
of 57